Recent Updates
Recently added Catalysts
BON Positive Sentiment Score: 65/100

BON NATURAL LIFE LIMITED AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) As of

Monday, September 29, 2025 1 min read
Key Takeaway: BON Natural Life Limited released its condensed consolidated balance sheets for the period ending March 31, 2025. The company reported total assets of $71.58 million, reflecting a growth from $61.77 million at the end of the previous period. Notably, net income attributable to the company improved compared to the prior period. However, the company also faced a comprehensive loss, showcasing challenges in profitability despite asset growth.

Market Sentiment Analysis

POSITIVE FACTORS

  • Total assets increased from $61.77 million to $71.58 million.
  • Net income attributable to BON Natural Life Limited improved to $169,227.
  • Significant increase in Class A Ordinary shares position, indicating potential growth.
  • Shareholder equity rose to $53.91 million, reflecting financial stability.

CONCERNS & RISKS

  • Total comprehensive income shows a significant loss of $1.22 million.
  • Accounts payable decreased, which may indicate potential cash flow issues.
  • Gross profit declined from $2.97 million to $1.91 million, suggesting a decrease in profitability.
  • Ongoing economic uncertainties reflected in foreign currency translation adjustments impacting overall profitability.

Full Press Release Details

BON NATURAL LIFE LIMITED AND
CONDENSED CONSOLIDATED BALANCE
As of
March 31, 2025 September 30, 2024
ASSETS
CURRENT ASSETS
Cash $ 8,894,053 $ 80,466
Restricted cash - 576,739
Accounts receivable, net 11,032,979 11,781,103
Inventories, net 2,673,140 1,572,224
Advance to suppliers, net 10,815,661 14,469,299
Due from related parties 4,048,147 33,228
Prepaid expenses and other current assets 5,000,480 4,296,949
Current assets held for sale associated with the sale of the Gansu subsidiary - 6,983,849
TOTAL CURRENT ASSETS 42,464,460 39,793,857
NON-CURRENT ASSETS
Property, plant and equipment, net 13,891,780 15,005,686
Intangible assets, net 742,924 776,995
Right-of-use lease assets, net 34,376 141,895
Deferred tax assets, net 1,342 1,388
Long-term others receivable 14,449,247 -
Non-current assets held for sale associated with the sale of the Gansu subsidiary - 6,045,611
TOTAL NON-CURRENT ASSETS 29,119,669 21,971,575
TOTAL ASSETS $ 71,584,129 $ 61,765,432
LIABILITIES AND EQUITY
CURRENT LIABILITIES
Short-term loans $ 7,586,798 $ 5,719,493
Current portion of long-term loans 878,587 461,765
Accounts payable 2,052,309 3,428,102
Due to related parties 118,965 244,871
Taxes payable 2,809,424 3,681,166
Deferred revenue 256,859 506,769
Accrued expenses and other current liabilities 3,680,273 2,243,219
Operating lease liability, current 20,002 148,904
Current liabilities held for sale associated with the sale of the Gansu subsidiary - 11,543
TOTAL CURRENT LIABILITIES 17,403,217 16,445,832
NON-CURRENT LIABILITIES
Long-term loans 275,607 970,061
275,607 970,061
TOTAL LIABILITIES $ 17,678,824 $ 17,415,893
COMMITMENTS AND CONTINGENCIES
EQUITY
Preferred shares ($0.001 par value, 50,000,000 preferred shares authorized, no shares were issued and outstanding as of March 31, 2025 and September 30, 2024) $ - $ -
Class A Ordinary shares ($0.025 par value, 1,000,000,000 shares authorized, 3,675,677 and 158,823 shares issued and outstanding as of March 31, 2025 and September 30, 2024, respectively*) 91,891 3,970
Class B Ordinary shares ($0.001 par value, 50,000,000 shares authorized, 2,041,839 and nil shares issued and outstanding as of March 31, 2025 and September 30, 2024, respectively) 2,042 -
Additional paid in capital 35,754,942 25,005,100
Statutory reserve 2,733,354 2,733,354
Retained earnings 18,910,912 18,741,685
Accumulated other comprehensive income (3,971,249 ) (2,577,418 )
TOTAL BON NATURAL LIFE LIMITED SHAREHOLDERS' EQUITY 53,521,892 43,906,691
Non-controlling interest 383,413 442,848
TOTAL SHAREHOLDERS' EQUITY 53,905,305 44,349,539
TOTAL LIABILITIES AND EQUITY $ 71,584,129 $ 61,765,432
*Retroactively restated to reflect
the Company's 1-for-25 share consolidation which was approved at extraordinary general meeting of the shareholders on April 15,
2025, and effective on May 19, 2025.
BON NATURAL LIFE LIMITED AND
CONDENSED CONSOLIDATED STATEMENTS
OF INCOME AND COMPREHENSIVE INCOME
For the six months ended March 31,
2025 2024
REVENUE $ 7,949,845 $ 10,183,553
COST OF REVENUE (6,041,997 ) (7,215,116 )
GROSS PROFIT 1,907,848 2,968,437
OPERATING EXPENSES
Selling expenses (68,317 ) (103,096 )
General and administrative expenses (1,459,009 ) (1,890,452 )
Research and development expenses (96,472 ) (890,384 )
Total operating expenses (1,623,798 ) (2,883,932 )
INCOME FROM OPERATIONS 284,050 84,505
OTHER INCOME (EXPENSES)
Interest income 116 161
Interest expense (164,584 ) (143,747 )
Unrealized foreign transaction exchange gain (loss) 79,748 (2,747 )
Government subsidies - 61,081
Other income (expenses) 113,834 49,683
Total other expenses, net 29,114 (35,569 )
INCOME BEFORE INCOME TAX PROVISION 313,164 48,936
INCOME TAX PROVISION (1 77 ,253 ) (90,734 )
NET INCOME (LOSS) 135,911 (41,798 )
Less: net loss attributable to non-controlling interest (33,316 ) (31,279 )
NET INCOME (LOSS) ATTRIBUTABLE TO BON NATURAL LIFE LIMITED $ 169,227 $ (10,519 )
NET INCOME (LOSS) $ 135,911 $ (41,798 )
OTHER COMPREHENSIVE INCOME
Total foreign currency translation adjustment (1,419,950 ) 367,971
TOTAL COMPREHENSIVE INCOME (1,284,039 ) 326,173
Less: comprehensive loss attributable to non-controlling interest (59,435 ) 126,222
COMPREHENSIVE INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED $ (1,224,604 ) $ 199,951
(LOSS) EARNINGS PER SHARE ATTRIBUTABLE TO CLASS A AND CLASS B ORDINARY SHARE
Basic* $ 0.56 $ (0.20 )
Dilute* $ 0.50 $ (0.20 )
WEIGHTED AVERAGE NUMBER OF CLASS A AND CLASS B ORDINARY SHARES OUTSTANDING
Basic* 302,647 51,428
Diluted* 336,070 51,428
*Retroactively restated to reflect the Company's
1-for-25 share consolidation which was approved at extraordinary general meeting of the shareholders on April 15, 2025, and effective
BON NATURAL LIFE LIMITED AND
CONDENSED CONSOLIDATED STATEMENTS
OF CHANGES IN SHAREHOLDERS' EQUITY
FOR THE SIX MONTHS ENDED MARCH
Class A Ordinary Shares Class B Ordinary Shares Additional paid-in Statutory Retained Accumulated other comprehensive Total shareholders' Non- controlling Total
Shares* Amount Shares Amount capital reserve earnings loss equity interest equity
Balance at September 30, 2023 46,955 $ 1,174 - $ - $ 18,088,056 $ 2,372,871 $ 18,703,996 $ (3,681,445 ) $ 35,484,652 $ 497,181 $ 35,981,833
Share-based compensation 9,600 240 - - 1,009,596 1,009,836 1,009,836
Net loss - - - - (10,519 ) (10,519 ) (31,279 ) (41,798 )
Foreign currency translation adjustment - - - - 210,470 210,470 157,501 367,971
Balance at March 31, 2024 56,555 $ 1,414 - $ - $ 19,097,652 $ 2,372,871 $ 18,693,477 $ (3,470,975 ) $ 36,694,439 $ 623,403 $ 37,317,842
Balance at September 30, 2024 158,823 $ 3,970 - $ - $ 25,005,100 $ 2,733,354 $ 18,741,685 $ (2,577,418 ) $ 43,906,691 $ 442,848 $ 44,349,539
Issuance of Class A Ordinary Shares for a public offering, net 3,590,528 89,763 - - 10,454,042 - - - 10,543,805 - 10,543,805
Issuance of Class B Ordinary shares (81,674 ) (2,042 ) 2,041,839 2,042 - - - - - - -
Share-based compensation 8,000 200 - - 295,800 - - - 296,000 - 296,000
Net income - - - - - - 169,227 - 169,227 (33,316 ) 135,911
Foreign currency translation adjustment - - - - - - - (1,393,831 ) (1,393,831 ) (26,119 ) (1,419,950 )
Balance at March 31, 2025 3,675,677 $ 91,891 2,041,839 $ 2,042 $ 35,754,942 $ 2,733,354 $ 18,910,912 $ (3,971,249 ) $ 53,521,892 $ 383,413 $ 53,905,305
*Retroactively restated to reflect
the Company's 1-for-25 share consolidation which was approved at extraordinary general meeting of the shareholders on April 15,
2025, and effective on May 19, 2025.
BON NATURAL LIFE LIMITED AND
CONDENSED CONSOLIDATED STATEMENTS
For the six months ended March 31,
2025 2024
Cash flows from operating activities
Net income (loss) $ 135,911 $ (41,798 )
Less: Net loss from discounted operation - (8,749 )
Net income from continuing operation 135,911 (33,049 )
Adjustments to reconcile net income to cash provided by operating activities
Allowance for doubtful accounts - 21,441
Depreciation and amortization 617,343 688,466
Inventory reserve - 58,349
Deferred income tax - (11,345 )
Amortization of operating lease right-of-use assets 107,519 115,882
Share-based compensation 296,000 1,009,836
Unrealized foreign currency exchange loss (gain) (79,848 ) 2,747
Changes in operating assets and liabilities:
Accounts receivable 361,239 (3,464,205 )
Inventories 232,466 (498,736 )
Advance to suppliers, net 9,964,799 (160,908 )
Prepaid expenses and other current assets 4,758,681 801,781
Long-term others receivable (14,500,947 ) -
Accounts payable (1,219,138 ) (135,111 )
Operating lease liabilities (128,902 ) (120,040 )
Taxes payable (753,138 ) (224,459 )
Deferred revenue (249,910 ) 391,057
Accrued expenses and other current liabilities (3,837,742 ) (314,702 )
Net cash (used in) provided by operating activities from continuing operation (4,295,567 ) (1,872,993 )
Net cash used in operating activities from discontinued operations - (11,180 )
Net cash used in operating activities (4,295,567 ) (1,884,173 )
Cash flows from investing activities
Purchase of property and equipment - (693 )
Proceeds from sales of property and equipment 4,395 -
Net cash used in investing activities from continuing operation 4,395 (693 )
Net cash used in investing activities from discontinued operations - -
Net cash used in investing activities 4,395 (693 )
Cash flows from financing activities
Net proceeds from issuance of ordinary shares 10,543,805 -
Proceeds from short-term loans 7,232,644 3,619,267
Proceeds from long-term loans - 854,514
Repayment of short-term loans (5,276,345 ) (1,534,052 )
Repayment of long-term loans (124,467 ) (510,128 )
Proceeds from (repayment of) borrowings from related parties (53,393 ) 80,752
Net cash provided by financing activities from continuing operation 12,322,244 2,510,353
Net cash provided by financing activities from discontinued operations - 1,499
Net cash provided by financing activities 12,322,244 2,511,852
Effect of changes of foreign exchange rates on cash 205,812 (21,858 )
Net increase (decrease) in cash 8,236,848 605,128
Cash, beginning of period 657,205 112,751
Cash, end of the period 8,894,053 717,879
Less: Cash of discontinued operations at the end of the period - 1,339
Cash of the continued operations at the end of period $ 8,894,053 $ 716,540
Supplemental disclosure of cash flow information
Cash paid for interest expense $ 164,584 $ 143,747
Cash paid for income tax $ - $ -
Supplemental disclosure of non-cash investing and financing activities
Amortization of share-based compensation for initial public offering services $ - $ 24,000
Right-of-use assets obtained in exchange for operating lease obligations $ - $ -

Frequently Asked Questions

What were the total assets as of March 31, 2025?

Total assets were $71,584,129.

How much net income did Bon Natural Life report for March 2025?

The net income was $135,911.

What was the gross profit for the six months ended March 31, 2025?

Gross profit was $1,907,848.

What is the total shareholders' equity on March 31, 2025?

Total shareholders' equity was $53,905,305.

How much did Bon Natural Life raise from share issuance in March 2025?

They raised $10,543,805 from share issuance.

Tags: BON Viatris Investor Conferences Healthcare financial results balance sheets net income shareholder equity
Last updated: Sep 29, 2025